Becton DickinsonBDX

NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices

Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.

Medtech & devices: Medical equipment and devices, from surgery and cardiology to robotics.

Key metrics

Market cap

$50.1B

Price

$190.74

Today

−0.7%

Return YTD

+25.8%

Return 1Y

+24.2%

P/E

53.2

P/S

2.4

P/B

2.1

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

MedtechDiagnostics exposureMedical consumablesDiagnosticsDrug delivery

In the value chain

Products & services

Medical consumables
Diagnostic systems
Drug delivery

Competitors

Medtronic
Abbott
Thermo Fisher

Risks

Mature markets
Announced business split

Supply chain

Supplies →

LabcorpLH Cardinal HealthCAH

Full supply chain for BDX →

Same segment: Medtech & devices

Intuitive SurgicalISRG StrykerSYK MedtronicMDT Boston ScientificBSX Edwards LifesciencesEW GE HealthCareGEHC ResMedRMD Zimmer BiometZBH

Compare BDX

BDX vs ISRG BDX vs SYK BDX vs MDT BDX vs BSX BDX vs EW BDX vs GEHC

See where Becton Dickinson sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →